Controlled Substance Monitoring Archives - Insights

When is it Cool to Drool? Oral Fluid Testing for Controlled Substance Monitoring

MCL Education — Wed, 30 Oct 2024 12:00:00 +0000

PACE/State of FL - Substance use disorders and the common laboratory tests and matrices used for controlled substance monitoring.

The post When is it Cool to Drool? Oral Fluid Testing for Controlled Substance Monitoring appeared first on Insights.

Visit Mayo Clinic Laboratories at the APA Annual Meeting

Carly Mouzes — Mon, 15 May 2023 12:00:00 +0000

Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and monitor therapeutic and illicit drugs across several relevant specimen types.

The post Visit Mayo Clinic Laboratories at the APA Annual Meeting appeared first on Insights.

Interpretation of qualitative and quantitative urine opiate tests for pain management patients

MCL Education — Mon, 03 May 2021 06:00:00 +0000

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.

The post Interpretation of qualitative and quantitative urine opiate tests for pain management patients appeared first on Insights.

High-resolution targeted stimulant and phencyclidine (PCP) screen

MCL Education — Mon, 05 Apr 2021 14:52:07 +0000

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed CNS stimulant medications.

The post High-resolution targeted stimulant and phencyclidine (PCP) screen appeared first on Insights.

Improving outcomes through comprehensive controlled substance monitoring

Robin Huiras-Carlson — Wed, 10 Mar 2021 13:30:00 +0000

Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new comprehensive Controlled Substance Monitoring Panel, developed by the Clinical and Forensic Toxicology Laboratory at Mayo Clinic Laboratories, offers in-depth analysis on more than 70 different prescription medications and illicit substances to provide clinicians with details and interpretations on patients’ controlled substance use lacking in other laboratory assays.

The post Improving outcomes through comprehensive controlled substance monitoring appeared first on Insights.

New High-Resolution Targeted Opioid Screen: Superior Sensitivity and Specificity to Evaluate Adherence to Prescribed Opioid Therapy

MCL Education — Mon, 13 Jul 2020 12:45:00 +0000

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed opioid pain-relieving medication.

The post New High-Resolution Targeted Opioid Screen: Superior Sensitivity and Specificity to Evaluate Adherence to Prescribed Opioid Therapy appeared first on Insights.